Furthermore, the combination of multiple biomarkers can improve diagnostic accuracy; for instance, integrating markers such as Aβ42, p-tau, and NfL allows for a more precise diagnosis of AD (184). This evidence concerns the gene MAPT and Alzheimer disease.